Therapeutic effect of Qiliqiangxin capsule combined on refractory heart failure
10.3760/cma.j.issn.1673-4246.2010.04.008
- VernacularTitle:芪苈强心胶囊为主治疗难治性心力衰竭的临床观察
- Author:
Qiang WANG
;
Jingbo SUN
;
Jun SHAO
- Publication Type:Journal Article
- Keywords:
Qiliqiangxin capsule;
Refractory heart failure;
Therapeutic effect
- From:
International Journal of Traditional Chinese Medicine
2010;32(4):305-306
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the therapeutic effect of Qiliqiangxin capsule combined on refractory heart failure.Methods 60 patients with refractory heart failure were randomly recruited into a control group and a therapeutic group. The control group received the conventional treatment, and the therapeutic group took Qiliqiangxin capsule on the base of the conventional treatment (3 times a day, 4 granules/each time) combined with 120 mg cAMP meglumine. Treatment in both group lasted 14 days. Results: After the treatment, the therapeutic group showed improvement in the symptoms of heart failure. Comparing with the control group, the difference was significant (P＜0.05). Conclusion The therapeutic effect of Qiliqiangxin capsule combined on refractory heart failure is satisfied and can improve the quality obviously.
